Scedosporium apiospermum is a filamentous fungus found worldwide in soil, polluted water, and decaying organic matter that can cause a range of infections in humans, from localized skin nodules in otherwise healthy people to life-threatening disseminated disease in those with weakened immune systems. It belongs to a group of molds historically lumped under the name Pseudallescheria boydii, and its clinical significance has grown as transplant medicine and immunosuppressive therapies have expanded the population at risk. Treatment centers on the antifungal drug voriconazole, often combined with surgery, but the organism’s intrinsic resistance to many standard antifungals makes managing these infections genuinely difficult.
A Fungus Hiding in Plain Sight
S. apiospermum thrives in environments most people walk through every day. Environmental surveys have recovered it from public park soils across multiple countries. In a study of ten public parks in Bangkok, the fungus was isolated from soil in eight of them, with S. apiospermum accounting for the large majority of Scedosporium isolates.1PLOS ONE. Environmental Screening for the Scedosporium apiospermum Species Complex in Public Parks in Bangkok, Thailand A survey of soil samples in Lebanon found about a quarter of sites positive for Scedosporium species, with S. apiospermum dominating at roughly 80% of isolates.2Frontiers in Cellular and Infection Microbiology. First environmental survey of Scedosporium species in Lebanon The fungus favors nutrient-rich soil with higher nitrogen and phosphorus content and tends to show up near agricultural land, compost, and areas with organic pollution.
For the vast majority of people with healthy immune systems, breathing in or contacting the spores does nothing. The human body’s defenses handle the fungus without incident. Problems arise under two broad circumstances: when the immune system is suppressed (by drugs or disease), or when a traumatic event, like a near-drowning, forces large amounts of contaminated water or soil deep into body tissues.
Taxonomy Is More Than Academic Here
You may see S. apiospermum referred to by older names, including Pseudallescheria boydii, in medical records and older literature. For years, mycologists treated them as the same organism in different reproductive forms. Molecular studies in the 2000s revealed that what was once considered a single species is actually a complex of several closely related but genetically distinct species.3PubMed Central. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species A 2008 study of 141 isolates confirmed that S. apiospermum and P. boydii are indeed separate species, and proposed the additional species Scedosporium dehoogii.4PubMed Central. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii
This distinction matters clinically because species within the complex can differ in their antifungal susceptibility profiles. That said, one research group has argued that the observed differences between S. apiospermum, S. boydii, and a related species are not always consistent, and no clear clinical differences between them have been established, leading them to define the group as the “S. apiospermum species complex.”5Fungal Biology. The ‘species complex’ issue in clinically relevant fungi: A case study in Scedosporium apiospermum In practical terms, when a lab identifies S. apiospermum, the treating physician knows they are dealing with a resistant mold that demands specific antifungal choices, regardless of exactly where the isolate falls within the complex.
Who Gets Infected and What It Looks Like
Infections caused by S. apiospermum fall into a few broad patterns depending on the patient’s immune status and how exposure happened.
In people with normal immune function, the most common presentation is mycetoma, a chronic, slowly progressive infection of the skin and deeper soft tissue that typically follows a minor wound. A case report from Taiwan describes a 52-year-old immunocompetent woman who developed recurrent nodular lesions on her foot over six years after minor trauma.6Dermatologica Sinica. Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and voriconazole This kind of localized infection can be stubborn but is rarely fatal. Eye infections (keratitis) also occur in otherwise healthy people, sometimes after contact lens misuse or plant-material trauma to the eye.
The picture changes dramatically in immunocompromised patients. People who have received organ transplants are especially vulnerable because the anti-rejection drugs they take suppress the very immune pathways needed to contain fungal growth. Case reports describe disseminated infection following heart transplantation, with the fungus spreading to the eye, muscles, and even forming a mass inside the heart.7Frontiers in Cardiovascular Medicine. Case report: Disseminated Scedosporium apiospermum infection with invasive right atrial mass in a heart transplant patient Renal transplant recipients have developed foot abscesses initially mistaken for ordinary bacterial infections.8PubMed Central. Prompt diagnosis of Scedosporium apiospermum soft tissue infection: Life-saving in a renal transplant recipient
Cystic fibrosis patients represent another high-risk group. The thick, sticky mucus in their airways traps fungal spores, allowing the fungus to colonize the lungs over months or years. S. apiospermum is considered one of the major fungal colonizers of cystic fibrosis airways.9PubMed. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation A German multicenter study found that colonized cystic fibrosis patients more frequently had allergic bronchopulmonary aspergillosis and co-colonization with a mucoid form of Pseudomonas aeruginosa.10PLOS ONE. Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors In one tragic case, chronic airway colonization progressed to a lung mycetoma and then to suspected brain involvement, ultimately proving fatal.11PubMed. Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis
Brain Infections After Near-Drowning
One of the most distinctive and alarming features of S. apiospermum is its association with brain abscesses following near-drowning events. When a person aspirates or swallows contaminated water, the fungus can enter through the lungs or sinuses and eventually reach the central nervous system. This can happen even in people with perfectly normal immune systems. A case report describes a 39-year-old healthy man who developed a brain abscess weeks after a near-drowning incident, with S. apiospermum isolated from the lesion.12PubMed. Lethal brain abscess due to the fungus Scedosporium apiospermum (teleomorph Pseudallescheria boydii) after a near-drowning incident: case report and review of the literature A 13-year-old boy who had been successfully resuscitated after near-drowning later developed a brain abscess and inflammation in the brain’s ventricles, with a fatal outcome.13PubMed Central. Scedosporium apiospermum: An Emerging Fatal Cause of Fungal Abscess and Ventriculitis after Near-drowning
While brain abscesses from S. apiospermum remain rare overall, they carry extremely high mortality. Most cases occur in immunocompromised individuals, but the near-drowning scenario is a well-recognized exception in which otherwise healthy people develop devastating central nervous system infections.14PubMed Central. Scedosporium apiospermum-induced brain abscess leading to rapid mortality in an immunocompetent adult male from Uttarakhand, India The delay between the drowning event and the appearance of neurological symptoms, which can be weeks, makes this diagnosis easy to miss. Clinicians who manage near-drowning survivors are increasingly aware of this risk, but early suspicion and imaging remain the key to catching it before it becomes untreatable.
Why This Fungus Is So Hard to Kill
S. apiospermum is intrinsically resistant to amphotericin B, the workhorse antifungal used against many other invasive molds. Under standard aerobic laboratory conditions, most strains show complete resistance to amphotericin B and to echinocandins, another major antifungal class.15iScience. Anaerobic growth and drug susceptibility of versatile fungal pathogen Scedosporium apiospermum This leaves azole antifungals, particularly voriconazole, as the primary weapon. But even azole susceptibility is not guaranteed.
The fungus has several tricks for surviving drug exposure. One important mechanism involves efflux pumps, molecular machinery in the cell membrane that actively ejects antifungal drugs before they can do damage. Research has shown that blocking these efflux pumps with an inhibitor can increase azole susceptibility significantly.16Medical Mycology. Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera The fungus also forms biofilms, communities of cells encased in a protective matrix that are much harder for both drugs and immune cells to penetrate. In mature biofilms, even efflux pump inhibition stops working well against azoles.16Medical Mycology. Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera
The fungus also protects itself with melanin, a dark pigment embedded in its cell wall. Experiments with mutants that cannot produce melanin showed that these unpigmented spores were more vulnerable to oxidizing conditions, high temperatures, and immune attack. Melanin essentially acts as armor, shielding the fungus from the body’s chemical weapons and environmental stresses alike.17PubMed Central. Deciphering the Role of PIG1 and DHN-Melanin in Scedosporium apiospermum Conidia Genomic analysis has revealed that several of these protective features, including melanin production, specialized cell wall components, and protein-degrading enzymes, appear to have expanded through gene duplication, suggesting the fungus has been evolving its survival toolkit over a long time.18PubMed Central. The genomes of Scedosporium between environmental challenges and opportunism
How Infections Are Diagnosed
Getting the right diagnosis quickly is a real challenge. S. apiospermum can look like other molds under the microscope, and it grows relatively slowly in culture, meaning days may pass before a lab has an answer. Colonies can be identified by their appearance and microscopic features, but visual identification alone is unreliable for distinguishing species within the complex. Molecular methods such as PCR provide more precise identification, and a technique called MALDI-TOF mass spectrometry has emerged as a fast and accurate way to identify clinical isolates at the species level.19PubMed Central. Time versus tissue: Timely identification of Scedosporium Rhinosinusitis in a post-COVID-19 case by MALDI-TOF MS leading to successful management
Speed matters because the choice of antifungal depends on the species. A patient started on amphotericin B for a presumed Aspergillus infection, for example, may be receiving a drug that does nothing against S. apiospermum. The sooner the lab pins down the actual organism, the sooner the treatment can be switched to something effective.
Treatment With Voriconazole and Beyond
Voriconazole is the cornerstone of treatment. A large clinical experience study of 107 patients found it demonstrated clinically useful activity against both S. apiospermum and the related species S. prolificans, and was generally well tolerated.20PubMed Central. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients It can be given intravenously for severe infections and then transitioned to oral tablets for longer-term treatment. However, clinicians have noted potential pitfalls in this intravenous-to-oral switch because absorption of the oral form can be unpredictable, which may lead to subtherapeutic drug levels if blood concentrations are not monitored closely.21PubMed Central. Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy
For localized infections like mycetoma, surgery plays a critical role alongside antifungals. Cutting out the infected tissue reduces the fungal burden in a way that drugs alone may not achieve. One case of recurrent foot mycetoma in Hungary was successfully treated with surgical excision plus terbinafine, a different class of antifungal.22PubMed Central. Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and terbinafine treatment: a case report and review of the literature In aggressive or disseminated disease, the combination of surgery and antifungal therapy is often considered essential.
When voriconazole alone is not enough, physicians sometimes try combination regimens. Adding an echinocandin (such as micafungin) to a triazole has been explored, though laboratory testing of these combinations has produced mixed results, with interactions ranging from no effect to occasional synergy or even antagonism, and lab-dish findings did not reliably predict outcomes in animal models.23Journal of Antimicrobial Chemotherapy. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii In one case report of disseminated infection, adding an echinocandin along with GM-CSF, an immune-stimulating drug that boosts white blood cell activity, provided partial recovery, hinting at a possible benefit from combining antifungals with immunotherapy.24Medical Mycology Case Reports. Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: A case report and review of the literature
How the Immune System Fights Back (and Where It Falls Short)
The body’s front-line defense against fungal invasion relies heavily on neutrophils, a type of white blood cell that engulfs and chemically destroys invaders. Research on S. apiospermum has shown that the fungus is susceptible to this immune attack, but to varying degrees depending on the strain. Strains that are resistant to amphotericin B also proved harder for neutrophils to damage, despite the immune cells generating more toxic molecules in response, suggesting the fungus may share overlapping defenses against both drug and immune attack.25PubMed Central. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury
Biofilms present an additional challenge to immune clearance. In laboratory experiments, neutrophils caused much less damage to S. apiospermum growing in biofilms compared to free-floating cells. But when voriconazole or amphotericin B formulations were added alongside the neutrophils, the combined effect was additive or even synergistic against biofilms.26Journal of Antimicrobial Chemotherapy. Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms This finding underscores why restoring or supporting immune function, whether by reducing immunosuppressive drugs where possible or adding immune-boosting agents, is an important consideration alongside antifungal therapy.
Eye Infections Deserve Special Mention
Fungal keratitis, an infection of the cornea, is one of the more common localized presentations of S. apiospermum in otherwise healthy individuals. A case series of 13 ocular infections found that most keratitis cases responded to a combination of topical natamycin plus an azole antifungal. However, two patients with sclerokeratitis, a deeper and more aggressive form, progressed despite treatment and ultimately required removal of the eye.27PubMed Central. Ocular infections caused by Scedosporium apiospermum: A case series
Voriconazole has shown particular promise for eye infections. In one reported case, a woman whose corneal infection relapsed after initial improvement on natamycin was switched to topical voriconazole and saw her vision improve dramatically within days, with the corneal defect healing within a week.28PubMed. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin In another case, a farmer with contact lens-related keratitis proved resistant to fluconazole and amphotericin B and did not respond to voriconazole either, ultimately requiring a corneal transplant.29PubMed Central. Scedosporium apiospermium keratitis: a case report The takeaway for eye infections is that outcomes vary a lot: many respond well to topical antifungals, but deeper or resistant infections can threaten sight permanently.
Hospital Clusters and Environmental Exposure
Because S. apiospermum lives in soil, any activity that disturbs earth near healthcare facilities can potentially expose vulnerable patients. An Australian report documented two clusters of Scedosporium infections at a hospital in autumn 2001 and 2003, both occurring during periods of building construction that required deep excavation. Air, dust, and soil sampling did not pinpoint the exact environmental source, but the temporal association was striking.30Emerging Infectious Diseases. Infection with Scedosporium apiospermum and S. prolificans, Australia This is a pattern familiar from other environmental molds: construction near hospitals has been linked to outbreaks of Aspergillus infections as well. Hospitals with ongoing transplant programs increasingly use dust barriers, HEPA filtration, and construction protocols to reduce the risk during building work.
Olorofim and the Search for New Drugs
Given the limited options available today, there is real urgency around developing new antifungals that work against S. apiospermum. The most promising candidate in development is olorofim, a drug with an entirely new mechanism of action. In animal studies, olorofim dramatically improved survival: all treated mice survived S. apiospermum infection out to ten days, compared with fewer than one in five untreated animals.31PubMed Central. In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis Laboratory testing has confirmed its activity against all Scedosporium species as well as the related and even more resistant species Lomentospora prolificans.32PubMed Central. In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans
Olorofim works by blocking an enzyme involved in building new DNA and RNA, a target no other approved antifungal hits. This means it should remain effective even against strains that have evolved resistance to azoles, echinocandins, and amphotericin B. The drug has not yet reached routine clinical use but is moving through the regulatory process, and clinicians who treat resistant mold infections are watching its progress closely. For patients with infections that do not respond to voriconazole, access through compassionate use or expanded access programs may already be available in some countries.
Research into the unusual behavior of S. apiospermum under low-oxygen conditions has also opened an unexpected door. Under anaerobic conditions (little or no oxygen), strains that are fully resistant to amphotericin B and echinocandins aerobically become sensitive to those same drugs.15iScience. Anaerobic growth and drug susceptibility of versatile fungal pathogen Scedosporium apiospermum This finding is still far from clinical application, but it raises the question of whether manipulating the oxygen environment around an infection, or understanding how oxygen levels within thick mucus or abscesses affect drug activity, could eventually be exploited therapeutically. For a fungus that seems to have a counter for everything medicine throws at it, any new angle is worth pursuing.